Alaunos Therapeutics, Inc. Derivative Liability, Fair Value of Collateral
Alaunos Therapeutics, Inc. (TCRT) had Derivative Liability, Fair Value of Collateral of $31.00 thousand as of 2025-06-09, per its 10-K filed 2026-03-31.
Financial Statements › Notes
us-gaap:DerivativeLiabilityFairValueOfCollateral · last filed 2026-03-31
- 2025-06-09: Derivative Liability, Fair Value of Collateral $31.00K.
- 2025-05-31: Derivative Liability, Fair Value of Collateral $177.00K.
| Period end | Derivative Liability, Fair Value of Collateral |
|---|---|
| 2025-06-09 | $31.00K 10-K · filed 2026-03-31 |
| 2025-05-31 | $177.00K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |